Clinical trial
Double-Blind, Placebo Controlled Trial of Metyrapone as Augmenting Agent in the Treatment of Major Depression
NCT00125554 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-Blind, Placebo Controlled Trial of Metyrapone as Augmenting Agent in the Treatment of Major Depression
- Lead sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 1998
- Completion date
- July 31, 2001
- Enrollment
- 63
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.